Displaying 701 - 720 of 4000
Joint Statement of Chair Lina M. Khan and Commissioner Rebecca Kelly Slaughter In the Matter of Napleton Automotive Group
Date
By
Lina M. Khan, Former Chair and Commissioner;
Rebecca Kelly Slaughter, Former Commissioner
Remarks of Chair Lina M. Khan at the Charles River Associates Conference, Competition & Regulation in Disrupted Times in Brussels, Belgium
Date
By
Lina M. Khan, Former Chair and Commissioner
Joint statement by Federal Trade Commission Chair Lina Khan and Didier Reynders, Commissioner for Justice of the European Commission
Date
By
Lina M. Khan, Former Chair and Commissioner
Remarks of Chair Lina M. Khan Regarding the Federal Trade Commission E-Cigarette Report for 2015-2018
Date
By
Lina M. Khan, Former Chair and Commissioner
Remarks of Samuel Levine at the Financial Literacy and Education Commission Public Meeting on Cryptocurrency Fraud and the Evolving Risks to Crypto Consumers
Date
By
Samuel Levine, Former Director, Bureau of Consumer Protection
Remarks of Chair Lina M. Khan at the White House Roundtable on the State of Labor Market Competition in the U.S. Economy
Date
By
Lina M. Khan, Former Chair and Commissioner
PLx Pharma Inc. (Vazalore aspirin product)
Resolution of NAD referral
Date
By
Carolyn L. Hann, Chief of Staff, Bureau of Consumer Protection
File
Resolution Letter
(165.13 KB)
Concurring Statement of Commissioners Noah Joshua Phillips and Christine S. Wilson Regarding Lifespan Corporation and Care New England Health System
Date
Matter Number
211 0031
Docket Number
9406
By
Christine S. Wilson, Former Commissioner;
Noah Joshua Phillips, Former Commissioner
File
Text of the Statement
(161.54 KB)
Concurring Statement of Commissioner Slaughter and Chair Khan regarding FTC and State of Rhode Island v. Lifespan Corporation and Care New England Health System
Date
Matter Number
2110031
By
Lina M. Khan, Former Chair and Commissioner;
Rebecca Kelly Slaughter, Former Commissioner
File
Remarks of Chair Lina M. Khan Regarding the 6(b) Study on Pharmacy Benefit Managers
Date
Matter Number
P221002
By
Lina M. Khan, Former Chair and Commissioner
File
Text of Statement
(195.96 KB)
Concurring Statement of Commissioners Noah Joshua Phillips and Christine S. Wilson Regarding Lifespan Corporation and Care New England Health System
Date
Matter Number
211 0031
Docket Number
9406
By
Christine S. Wilson, Former Commissioner;
Noah Joshua Phillips, Former Commissioner
File
Text of the Statement
(161.54 KB)
Concurring Statement of Commissioner Slaughter and Chair Khan regarding FTC and State of Rhode Island v. Lifespan Corporation and Care New England Health System
Date
Matter Number
2110031
By
Lina M. Khan, Former Chair and Commissioner;
Rebecca Kelly Slaughter, Former Commissioner
File
Statement of Commissioner Rebecca Kelly Slaughter Regarding the Advance Notice of Proposed Rulemaking on the Use of Earnings Claims
Washington, D.C.
Date
By
Rebecca Kelly Slaughter, Former Commissioner
Remarks of Chair Lina M. Khan Regarding the Advance Notice of Proposed Rulemaking on Earnings Claims
Date
By
Lina M. Khan, Former Chair and Commissioner
File
Text of Remarks
(177.5 KB)
Comment Submission of Chair Lina M. Khan Regarding the 1995 Bank Merger Competitive Review Guidelines
Date
By
Lina M. Khan, Former Chair and Commissioner
Letter from FTC Chair Khan to Senators Durbin, Grassley, Klobuchar, and Lee re State Antitrust Enforcement Venue Act of 2021
Date
By
Lina M. Khan, Former Chair and Commissioner
File
Text of the letter
(135.71 KB)
Joint Statement of Commissioners Noah Joshua Phillips and Christine S. Wilson Regarding Grant of Prior Approval Application of Sartorius Stedim Biotech S.A. for the Acquisition of Novasep Process SAS
Date
Matter Number
C4710
By
Noah Joshua Phillips, Former Commissioner;
Christine S. Wilson, Former Commissioner
Displaying 701 - 720 of 4000
Join us at the FTC!